This country profile provides an overview of Burkina Faso’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage increased from 77% in 2018 to 80% in 2019.
Burkina Faso is conducting post-preventive chemotherapy surveillance.
Burkina Faso does not require mass treatment for intestinal worms.
Treatment coverage decreased from 100% in 2018 to 83% in 2019.
Treatment coverage remained at 82% in 2018 and 2019.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Burkina Faso.